Abstract:Between January 1997 and December 1998, 30 consecutive children with suspected biliary atresia (BA) were selected to assess whether duodenal intubation (DI) and testing of aspirate for bile would help to rule out BA. Duodenal fluid was aspirated every 2 h for 24 h and tested for bile. A HIDA scan was also done in all cases. Every patient underwent a peroperative cholangiogram (POC) and liver biopsy; a Kasai portoenterostomy was done in indicated cases. In 22 cases all three investigations (DI, HIDA scan, POC) … Show more
“…If the color of duodenal fluid was bile-pigmented yellow, the patency of the extrahepatic bile duct was proved, and BA was denied. DTT was first reported in 1979 (5) and several studies explore the efficacy of DTT (6)(7)(8)(9)(10). In previous studies, the outcome of DTT was accessed by the color of duodenal fluid, and they showed high sensitivity (90.6%-100%) and relatively low specificity (60%-93.7%).…”
Section: Discussionmentioning
confidence: 99%
“…In DTT, a nasoduodenal tube is passed into the third portion of the duodenum, and duodenal fluid is collected to examine the presence of bile (3). Although several studies have evaluated the accuracy of DTT in the diagnosis of BA, the sensitivity and specificity of bile‐negative or bile‐positive DTT have been assessed by the color of duodenal fluid (5–10), and quantitative and objective values were not present. In this study, we assessed bile‐negative or bile‐positive DTT using duodenal total bile acid (TBA) concentrations in combination with serum markers and examined its efficacy as a screening method to rule out BA.…”
“…If the color of duodenal fluid was bile-pigmented yellow, the patency of the extrahepatic bile duct was proved, and BA was denied. DTT was first reported in 1979 (5) and several studies explore the efficacy of DTT (6)(7)(8)(9)(10). In previous studies, the outcome of DTT was accessed by the color of duodenal fluid, and they showed high sensitivity (90.6%-100%) and relatively low specificity (60%-93.7%).…”
Section: Discussionmentioning
confidence: 99%
“…In DTT, a nasoduodenal tube is passed into the third portion of the duodenum, and duodenal fluid is collected to examine the presence of bile (3). Although several studies have evaluated the accuracy of DTT in the diagnosis of BA, the sensitivity and specificity of bile‐negative or bile‐positive DTT have been assessed by the color of duodenal fluid (5–10), and quantitative and objective values were not present. In this study, we assessed bile‐negative or bile‐positive DTT using duodenal total bile acid (TBA) concentrations in combination with serum markers and examined its efficacy as a screening method to rule out BA.…”
“…The use of endoscopic retrograde cholangiopancreatography (ERCP) has been proposed for identification of the extrahepatic biliary tree, although it requires considerable technical expertise and general anesthesia, and the proper sized side‐viewing endoscope is not widely available (100,101). Finally, several groups have reported the usefulness of analyzing a duodenal bile specimen for presence of bilirubin or bile acids (102,103) as a test to demonstrate patency of the extrahepatic biliary tree.…”
Section: Diagnosis Of Neonatal Cholestatic Disordersmentioning
confidence: 99%
“…able technical expertise and general anesthesia, and the proper sized side-viewing endoscope is not widely available (100,101). Finally, several groups have reported the usefulness of analyzing a duodenal bile specimen for presence of bilirubin or bile acids (102,103) as a test to demonstrate patency of the extrahepatic biliary tree.…”
Section: Diagnosis Of Neonatal Cholestatic Disordersmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.